[Answered] An optimal ratio of omega-3 to omega-6 fatty acid consumption is 4:1. Indicate whether the ...

This topic contains a solution. Click here to go to the answer

Author Question: An optimal ratio of omega-3 to omega-6 fatty acid consumption is 4:1. Indicate whether the ... (Read 28 times)

mckennatimberlake

Hero Member
Posts: 559

on: Aug 6, 2018

An optimal ratio of omega-3 to omega-6 fatty acid consumption is 4:1.
Indicate whether the statement is true or false

Question 2

Your weight training goals should be specific and measurable.

Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

robbielu01

Sr. Member
Posts: 336

Reply #1 on: Aug 6, 2018

Answer to Question 1

TRUE

Answer to Question 2

T

mckennatimberlake

Hero Member
Posts: 559

Reply #2 on: Aug 6, 2018

Thanks

robbielu01

Sr. Member
Posts: 336

Reply #3 on: Aug 6, 2018

Welcome

« previous next »

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.